Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

65 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database.
Pellegrini M, Nicolay U, Lindert K, Groth N, Della Cioppa G. Pellegrini M, et al. Among authors: della cioppa g. Vaccine. 2009 Nov 16;27(49):6959-65. doi: 10.1016/j.vaccine.2009.08.101. Epub 2009 Sep 12. Vaccine. 2009. PMID: 19751689
Aflunov®: a vaccine tailored for pre-pandemic and pandemic approaches against influenza.
Del Giudice G, Fragapane E, Della Cioppa G, Rappuoli R. Del Giudice G, et al. Among authors: della cioppa g. Expert Opin Biol Ther. 2013 Jan;13(1):121-35. doi: 10.1517/14712598.2013.748030. Epub 2012 Nov 29. Expert Opin Biol Ther. 2013. PMID: 23189937 Review.
Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study.
Heikkinen T, Young J, van Beek E, Franke H, Verstraeten T, Weil JG, Della Cioppa G. Heikkinen T, et al. Among authors: della cioppa g. Am J Obstet Gynecol. 2012 Sep;207(3):177.e1-8. doi: 10.1016/j.ajog.2012.07.007. Epub 2012 Jul 16. Am J Obstet Gynecol. 2012. PMID: 22939717
Safety of MF59-adjuvanted influenza vaccination in the elderly: results of a comparative study of MF59-adjuvanted vaccine versus nonadjuvanted influenza vaccine in northern Italy.
Villa M, Black S, Groth N, Rothman KJ, Apolone G, Weiss NS, Aquino I, Boldori L, Caramaschi F, Gattinoni A, Malchiodi G, Crucitti A, Della Cioppa G, Scarpini E, Mavilio D, Mannino S. Villa M, et al. Among authors: della cioppa g. Am J Epidemiol. 2013 Oct 1;178(7):1139-45. doi: 10.1093/aje/kwt078. Epub 2013 Jul 17. Am J Epidemiol. 2013. PMID: 23863759 Free PMC article.
Challenges in early clinical development of adjuvanted vaccines.
Della Cioppa G, Jonsdottir I, Lewis D. Della Cioppa G, et al. Vaccine. 2015 Jun 8;33 Suppl 2:B47-51. doi: 10.1016/j.vaccine.2015.02.031. Vaccine. 2015. PMID: 26022568 Review.
Safety and immunogenicity of an MF59-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age.
Knuf M, Leroux-Roels G, Rümke HC, Abarca K, Rivera L, Lattanzi M, Pedotti P, Arora A, Kieninger-Baum D, Della Cioppa G. Knuf M, et al. Among authors: della cioppa g. Vaccine. 2015 Jan 1;33(1):174-81. doi: 10.1016/j.vaccine.2014.10.085. Epub 2014 Nov 11. Vaccine. 2015. PMID: 25444803 Clinical Trial.
Immunogenicity and tolerability of an MF59-adjuvanted, egg-derived, A/H1N1 pandemic influenza vaccine in children 6-35 months of age.
Knuf M, Leroux-Roels G, Rümke HC, Abarca K, Rivera L, Lattanzi M, Pedotti P, Arora A, Kieninger-Baum D, Della Cioppa G. Knuf M, et al. Among authors: della cioppa g. Pediatr Infect Dis J. 2014 Dec;33(12):e320-9. doi: 10.1097/INF.0000000000000462. Pediatr Infect Dis J. 2014. PMID: 24978857 Clinical Trial.
A cell culture-derived MF59-adjuvanted pandemic A/H7N9 vaccine is immunogenic in adults.
Bart SA, Hohenboken M, Della Cioppa G, Narasimhan V, Dormitzer PR, Kanesa-Thasan N. Bart SA, et al. Among authors: della cioppa g. Sci Transl Med. 2014 Apr 30;6(234):234ra55. doi: 10.1126/scitranslmed.3008761. Sci Transl Med. 2014. PMID: 24786323 Free article. Clinical Trial.
A dose-ranging study in older adults to compare the safety and immunogenicity profiles of MF59®-adjuvanted and non-adjuvanted seasonal influenza vaccines following intradermal and intramuscular administration.
Della Cioppa G, Nicolay U, Lindert K, Leroux-Roels G, Clement F, Castellino F, Galli C, Groth N, Levin Y, Del Giudice G. Della Cioppa G, et al. Hum Vaccin Immunother. 2014;10(6):1701-10. doi: 10.4161/hv.28618. Epub 2014 Apr 14. Hum Vaccin Immunother. 2014. PMID: 24732325 Free PMC article.
Superior immunogenicity of seasonal influenza vaccines containing full dose of MF59 (®) adjuvant: results from a dose-finding clinical trial in older adults.
Della Cioppa G, Nicolay U, Lindert K, Leroux-Roels G, Clement F, Castellino F, Galli G, Groth N, Del Giudice G. Della Cioppa G, et al. Hum Vaccin Immunother. 2012 Feb;8(2):216-27. doi: 10.4161/hv.18445. Epub 2012 Feb 1. Hum Vaccin Immunother. 2012. PMID: 22426371 Clinical Trial.
65 results
Jump to page
Feedback